Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00513591 · ClinicalTrials.gov registry record
Duke Autoimmunity in Pregnancy Registry
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 513
- Enrollment target
NCT00513591 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 513 participants.
The verdict
NCT00513591 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 513 participants
- Enrollment target
Study Summary
It is difficult to predict how a women with an autoimmune disease will do during pregnancy. Some women will improve, others will worsen. Some pregnancies progress normally and others become very complicated. The Duke Autoimmunity in Pregnancy (DAP) Registry will enroll women with autoimmune diseases, such as lupus, rheumatoid arthritis, scleroderma, and Sjogren's syndrome who wish to become, or already are, pregnant. We will follow these women throughout pregnancy to better understand how their autoimmune disease affects their pregnancy, and vice versa.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 513 participants |
| Start Date | 2007-08 |
| Est. Completion | 2018-11-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00513591
The ClinicalTrials.gov registry entry for NCT00513591 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 513 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00513591 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00513591 about?
NCT00513591 is a clinical study titled "Duke Autoimmunity in Pregnancy Registry". It is difficult to predict how a women with an autoimmune disease will do during pregnancy. Some women will improve, others will worsen. Some pregnancies progress normally and others become very complicated. The Duke Autoimmunity in Pregnancy (DAP) Registry will enroll women with autoimmune disease...
What is the current status of trial NCT00513591?
This trial is currently completed. The enrollment target is 513 participants. The study started on 2007-08. Estimated completion is 2018-11-19.
Who is sponsoring clinical trial NCT00513591?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.